Table 2 Bleeding events and Cerebrovascular accidents
From: The use of enoxaparin as bridge to therapeutic INR after LVAD implantation
LMWH | UFH | |
|---|---|---|
Index admission | N = 43 | N = 207 |
Bleeding (%) | 5 (11.6) | 24 (11.6) |
CVA (%) | 1 (2.3) | 11 (5.3) |
Follow-up | N = 67 | N = 181 |
Bleeding (%) | 7 (10.5) | 27 (14.9) |
CVA (%) | 1 (1.5) | 0 (0) |